Role of iron in anaemic critically ill patients: it's time to investigate!

被引：18

作者：

Piagnerelli, M ^{[1
]}

Vincent, JL ^{[1
]}

机构：

[1] Free Univ Brussels, Erasme Hosp, Dept Intens Care, B-1050 Brussels, Belgium

来源：

CRITICAL CARE | 2004年 / 8卷 / 05期

关键词：

anaemia; erythropoietin; iron; red blood cell;

D O I：

10.1186/cc2884

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Anaemia is a common problem in critically ill patients admitted to intensive care units. Many factors can be involved in its development, including rapid alterations in iron metabolism. Maintenance of iron homeostasis is a prerequisite for many essential biological processes and is a central element for the development of erythroid precursors and mature red blood cells. With the inflammatory process, iron distribution is disturbed, with decreased serum iron levels and increased iron stores. Little information is available on the precise role of alterations in iron metabolism in the development of iron anaemia in critically ill patients.

引用

页码：306 / 307

页数：2

共 20 条

[1] Time course of hemoglobin concentrations in nonbleeding intensive care unit patients [J].

Ba, VN ;

Bota, DP ;

Mélot, C ;

Vincent, JL .

CRITICAL CARE MEDICINE, 2003, 31 (02) :406-410

[2] Erythropoietin-induced rheological changes of rat erythrocytes [J].

Bor-Kucukatay, M ;

Yalcin, O ;

Meiselman, HJ ;

Baskurt, OK .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) :82-88

[3] Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. [J].

Casadevall, N ;

Nataf, J ;

Viron, B ;

Kolta, A ;

Kiladjian, J ;

Martin-Dupont, P ;

Michaud, P ;

Papo, T ;

Ugo, V ;

Teyssandier, I ;

Varet, B ;

Mayeux, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07) :469-475

[4] Efficacy of recombinant human erythropoietin in critically ill patients - A randomized controlled trial [J].

Corwin, HL ;

Gettinger, A ;

Pearl, RG ;

Fink, MP ;

Levy, MM ;

Shapiro, MJ ;

Corwin, MJ ;

Colton, T .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (22) :2827-2835

[5] Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial [J].

Corwin, HL ;

Gettinger, A ;

Rodriguez, RM ;

Pearl, RG ;

Gubler, KD ;

Enny, G ;

Colton, T ;

Corwin, MJ .

CRITICAL CARE MEDICINE, 1999, 27 (11) :2346-2350

[6] Bench-to-bedside review:: Iron metabolism in critically ill patients [J].

Darveau, M ;

Denault, AY ;

Blais, N ;

Notebaert, É .

CRITICAL CARE, 2004, 8 (05) :356-362

[7] Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietin [J].

Fillet, G ;

Beguin, Y .

ACTA CLINICA BELGICA, 2001, 56 (03) :146-154

[8] Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation [J].

Ganz, T .

BLOOD, 2003, 102 (03) :783-788

[9] A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care [J].

Hébert, PC ;

Wells, G ;

Blajchman, MA ;

Marshall, J ;

Martin, C ;

Pagliarello, G ;

Tweeddale, M ;

Schweitzer, I ;

Yetisir, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :409-417

[10] Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice [J].

Lee, TS ;

Chau, LY .

NATURE MEDICINE, 2002, 8 (03) :240-246

← 1 2 →